The coronavirus (COVID-19) pandemic continues to evolve globally. How to detect the SARS-COV-2 infection? How far are we from a vaccine or cure? Learn more about the reagents used for detection and research, latest news, research advance, and join us in the discussion.

New Bench to Bedside now online: Messenger RNA vaccines against SARS-CoV-2. The first two vaccines proven to be effective for inhibiting COVID-19 illness were both mRNA, achieving 95% efficacy (and safety) among 74,000 participants (half receiving placebo) after intramuscular ...Learn More

The presence of traces of SARS-CoV-2 in wastewater is proved to be an effective tool to determine the infection of communities. Although the virus is inactivated in water at room temperature, as is the case with other similar viruses, remnants of its genome can be detected by qPCR ...Learn More

The dramatic success of two COVID-19 vaccines in clinical trials last month marked a triumph for a previously unproven medical technology. The vaccines, one of which was authorized for emergency use by the U.S. Food and Drug Administration last week, rely on the genetic ...Learn More

Infection with SARS-CoV-2 not only damage the lung but also the brain It is well known that COVID-19 mainly damages the lung of a patient and bring about inflammatory response characterized by impairment to deep airways and alveoli. With the deepening of research, researchers ...Learn More

Although titanic efforts are being made for the development of treatments against the novel SARS-CoV-2 disease (COVID-19) and the approval of the recently developed vaccines by the Food and Drug Administration (FDA) and counterpart regulatory agencies such as the European ...Learn More

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2020 MolecularCloud